Tecnisco
2962
Tokyo Board Industries
7815
Liberta
4935
Reyuu Japan
9425
BlueMeme
4069
JP Stock MarketDetailed Quotes
2160 GNI Group
- 3180
- +105+3.41%
20min DelayTrading Jan 21 09:25 JST
159.51BMarket Cap19.21P/E (Static)
3180High3105Low167.30KVolume3125Open3075Pre Close526.17MTurnover386552wk High0.35%Turnover Ratio50.16MShares153752wk Low145.55EPS TTM150.41BFloat Cap4070Historical High19.21P/E (Static)47.30MShs Float13Historical Low165.56EPS LYR2.44%Amplitude--Dividend TTM4.32P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Hideaki Sashiwa
- Independent Director
- --
- Zhang Ping
- Independent Director
- --